Gene therapy treatment increasing body's signal for new blood vessel growth shows promise
Final 12-month data from the EXACT trial demonstrates safety and efficacy results for a vascular endothelial growth factor ...
Daily1h
Novel Combination Therapy Xanomeline-Trospium Promising for Treatment of Schizophrenia: JAMA
Researchers have found that the investigational combination of xanomeline-trospium (KarXT) is effective and well-tolerated in ...
Here's Why You Don't Need IV Vitamin Therapy
IV vitamin drips are marketed to offer a wide range of benefits, but there's no evidence to support these claims. In some ...
Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
RMAT designation follows FDA’s review of available safety and efficacy data from the first three patients dosed with the low ...
MedPage Today on MSN1d
Glecirasib Shows Promising Efficacy in KRAS-Mutated NSCLC
"Efficacy [with glecirasib] appears to be trending in the right ... and what its role will be in combination therapy.
Buy Recommendation for DNLI: Promising Safety and Efficacy of Denali’s ALS Drug DNL343
Denali Therapeutics (DNLI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
Science-Based Medicine3d
We finally learn from TACT2 what we should have known two decades ago: Chelation therapy doesn’t work for heart disease
At SBM, we've long argued that chelation therapy for heart disease is quackery. An abstract presented recently finally ...
FierceBiotech13d
Barinthus' HPV therapy proves safety, but not efficacy
Barinthus Biotherapeutics has hit the primary endpoint of a phase 1b/2 trial by showing its treatment for high-risk human ...
The American Journal of Managed Care10d
Review Finds Anti-BCMA CAR T-Cell Therapy Effective in Patients With MM
A new meta-analysis of chimeric antigen receptor (CAR) T-cell therapy in patients with multiple myeloma (MM) suggests the ...
The American Journal of Managed Care1d
Bimekizumab Shows Sustained Efficacy in Treating Axial Spondyloarthritis for 52 Weeks
Results from a study presented at the Academy of Managed Care Pharmacy 2024 annual meeting demonstrated sustained efficacy of ...
Weight Loss Drug Zepbound May Help Sleep Apnea, Study Finds
The U.S. Food and Drug Administration (FDA) approved Zepbound for the treatment of obesity in November 2023. Some prescribe ...
In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy
Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery ...